TSTstarr + for Treatment of Severe Prolapsed Hemorrhoids --- a Multi-center Randomized Controlled Clinical Trail

TSTstarr+ in the treatment of severe hemorrhoids prolapse--A multi center randomized controlled clinical trial.The aim of this stuy is to compare the first year hemorrhoids recurrence rate of TSTstarr+ and PPH in the treatment of severe hemorrhoids.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

780

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • severe prolapsed hemorrhoids
  • no significant anal-malformation before operation
  • having signed the informed consent.

Exclusion Criteria:

  • needing emergency operation or having previous history of hemorrhoids operation
  • with other anal diseases at the same time such as : anal fissure, anal fistula and perianal abscess and so on
  • diagnosed with inflammatory bowel disease or proctitis
  • diagnosed with colorectal cancer
  • associated with cardiovascular and cerebrovascular diseases and other diseases so that can not tolerate surgery or increase the risk of surgery
  • with chronic or acute renal insufficiency patients
  • coagulation abnormalities or with anticoagulation treatment at present
  • diagnosed with diabetes with poor glycemic control
  • in women with pregnant or menstruation
  • The intellectual disabilities or mental disorder
  • had participated in other clinical trial before we selected 4 weeks
  • other severe complications.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: group A( TSTstarr+ group)
TSTstarr+ is a kind of modified STARR(stapled transanal rectal resection ) operation, compared to the traditional STARR operation, it does not need two staplers but with a larger diameter stapler, " +" means better . Patients in group A with severe prolapsed hemorrhoids will undergo TSTstarr+ operation .
TSTstarr+ : a kind of modified STARR(stapled transanal rectal resection ) operation, compared to the traditional STARR operation, it does not need two staplers but with a larger diameter stapler, " +" means better . Patients in group A with severe prolapsed hemorrhoids will undergo TSTstarr+ operation .
ACTIVE_COMPARATOR: group B ( PPH group)
PPH is short fo procedure for prolapsed hemorrhoids .Patients in group B with severe prolapsed hemorrhoids will undergo PPH operation.
PPH is short fo procedure for prolapsed hemorrhoids .Patients in group B with severe prolapsed hemorrhoids will undergo PPH operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the recurrence rate of the severe prolapsed Hemorrhoids after surgery
Time Frame: 2 years
780 patients will be enrolled in one year.All patients will be followed up for one year, and then calculate 1 year recurrence rate between TSTstarr+ group and PPH group
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Operation time
Time Frame: 1 year
1 year
Intraoperative hemorrhage
Time Frame: 1 year
1 year
The weight of specimens
Time Frame: 1year
1year
The volume of specimens
Time Frame: 1year
1year
The number of patients with anal pain after surgery
Time Frame: 2 years
2 years
The number of patients with fecal urgency after surgery
Time Frame: 2 years
2 years
The number of patients with stricture of anus after surgery
Time Frame: 2 years
2 years
The number of patients with hemorrhage after surgery
Time Frame: 2 years
2 years
The number of patients with retention of urine in the early time after surgery
Time Frame: 2 years
2 years
The number of patients with edema of the anal margin in the early time after surgery
Time Frame: 2 years
2 years
The time of returning to normal
Time Frame: 2 years
2 years
The total cost of hospitalization
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (ANTICIPATED)

April 1, 2016

Study Completion (ANTICIPATED)

October 1, 2016

Study Registration Dates

First Submitted

November 5, 2014

First Submitted That Met QC Criteria

November 19, 2014

First Posted (ESTIMATE)

November 20, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

November 20, 2014

Last Update Submitted That Met QC Criteria

November 19, 2014

Last Verified

October 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemorrhoids

3
Subscribe